DexCom, Inc. (DXCM) has a MoatMap StockRank of 68/100 based on Quality (76/100), Value (27/100), and Momentum (47/100) factor scores. The current signal is BUY. DexCom, Inc. is a leader in continuous glucose monitoring (CGM) systems. It exhibits exceptionally strong quality ('Q: 80') and operates in a high-growth healthcare niche with significant switching costs for patients and providers, fitting the 'Durable Quality & Moats' theme. While there isn't a specific macro *inflection point* creating an asymmetric *new* opportunity, its continued penetration into the massive diabetes market, combined with product innovation, offers a powerful compounding story. The very low 'V: 24' suggests it is expensive, and 'M: 50' is moderate, implying the market may already appreciate its quality and growth. This is a quality compounder, but the asymmetric *macro* angle is less pronounced.